XML 14 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash Flows from Operating Activities    
Net (loss) income $ (16,877,000) $ 2,304,000
Non-cash items included in net income    
Depreciation and amortization 7,640,000 5,689,000
Deferred income taxes (5,650,000) (947,000)
Impairment of goodwill and intangible asset 28,000,000 479,000
Fixed asset impairment and accelerated depreciation 354,000
Deferred compensation plan (541,000) 196,000
Stock compensation expense 1,754,000 2,292,000
Issuance of common shares as compensation 234,000 331,000
(Gain) loss on disposition of fixed assets (28,000) 52,000
(Gain) on the sale of the building (1,361,000)
Allowance for doubtful accounts 144,000 248,000
Inventory obsolescence reserve 1,762,000 981,000
Changes in certain assets and liabilities:    
Accounts receivable (793,000) 5,189,000
Inventories (3,441,000) 3,190,000
Refundable income taxes 435,000 (143,000)
Accounts payable (3,077,000) (965,000)
Accrued expenses and other (3,243,000) (5,119,000)
Customer prepayments 575,000 174,000
Net cash flows provided by operating activities 6,894,000 12,944,000
Cash Flows from Investing Activities    
Purchases of property, plant and equipment (2,178,000) (3,534,000)
Acquisition of business, net of cash received and warrants issued (95,077,000)
Proceeds from sale of fixed assets 1,526,000 3,081,000
Net cash flows used in investing activities (652,000) (95,530,000)
Cash Flows from Financing Activities    
Payments of long-term debt (77,817,000) (14,882,000)
Borrowings of long-term debt 73,408,000 69,649,000
Cash dividends paid (3,845,000) (3,772,000)
Exercise of stock options 285,875 2,612,578
Purchase of treasury shares (107,000) (446,000)
Issuance of treasury shares 873,000 176,000
Net cash flows provided by (used in) financing activities (7,226,000) 53,126,000
Decrease in cash and cash equivalents (984,000) (29,460,000)
Cash and cash equivalents at beginning of period 3,039,000 33,835,000
Cash and cash equivalents at end of period $ 2,055,000 $ 4,375,000